Recombinant Mouse SEZ6L2 Protein
Beta LifeScience
SKU/CAT #: BLK-01406P-100UG

Mouse SEZ6L2 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Mouse SEZ6L2 Protein
Beta LifeScience
SKU/CAT #: BLK-01406P-100UG
Collections: High-quality recombinant proteins, Other recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Mouse SEZ6L2 Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Leu28-Asn844. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | Q4V9Z5 |
Target Symbol | SEZ6L2 |
Synonyms | BSRP-A; PSK-1; SEZ6L2; UNQ1903/PRO4349 |
Species | Mouse |
Expression System | HEK293 |
Tag | C-His |
Expression Range | Leu28-Asn844 |
Mol. Weight | The protein has a predicted MW of 88.5 kDa. Due to glycosylation, the protein migrates to 115-140 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | Seizure-related 6 homolog (mouse)-like 2 (SEZ6L2) was shown to be involved in transcription of a type 1 transmembrane protein for regulating cell fate. SEZ6L2 was significantly up-regulated in tumour tissues of patients with CRC compared with adjacent normal tissues. Up-regulation of SEZ6L2 was correlated with a poor prognosis in patients with CRC. Furthermore, SEZ6L2 expression was inversely correlated with the expression of cytochrome C in malignant tissues in patients with CRC. |